Search - tctmd.com

Displaying 321 - 340 of 602

Sort: Relevancy | Date

News Conference News EuroPCR 2014

Global SYMPLICITY Substudy Teases out Reasons for Non-response in Real-World Patients

Yael L. Maxwell

May 22, 2014

News Daily News

Many Patients Referred for Renal Denervation Improve with Medication Adjustment

May 12, 2014

Presentation

Eligibility for Renal Denervation: Experience at 11 European Expert Centers

Presenter: A. Persue

May 12, 2014

News Daily News

A-fib, Dialysis Dramatically Worsen Outlook for TAVR Patients with Advanced CKD

May 07, 2014

News Daily News

Renal Denervation Shows Promise in Patients Refractory to Stenting

L.A. McKeown

May 02, 2014

$Renal Denervation for Hypertension Refractory to Renal Artery Stenting$

Presentation

Renal Denervation for Hypertension Refractory to Renal Artery Stenting

Presenter: Yvonne Bausback

May 02, 2014

Presentation

ACC 2014 Late Breaking Trials Renal Denervation for Resistant Hypertension

Presenter: Gregg W. Stone

April 28, 2014

Presentation Fellows 2014

Renal Artery Intervention and Denervation for Resistant Hypertension

Presenter: Duane Pinto

April 14, 2014

News Conference News ACC 2014

ACC/i2 2014: Cardiologists Carefully Consider TAVR, Renal Denervation

Yael L. Maxwell

April 03, 2014

News Conference News ACC 2014

Global SYMPLICITY Registry Still Shows Positive Results for Renal Denervation

Yael L. Maxwell

March 30, 2014

News Conference News ACC 2014

Renal Denervation Fails to Meet Efficacy Endpoints Compared with Placebo Procedure

Yael L. Maxwell

March 29, 2014

News Daily News

Una Prueba No Invasiva asocia el Volumen de Fluido Pre-Angiografía a Futuros Daños Renales

Caitlin E. Cox

February 12, 2014

News Daily News

Noninvasive Test Links Pre-Angiography Fluid Volume to Later Kidney Damage

Caitlin E. Cox

February 12, 2014

Presentation

Preprocedural Bioimpedance Vectorial Analysis (BIVA) of Fluid Status and Prediction of Contrast-Induced AKI

Presenter: 232162|Mauro Maioli

February 11, 2014

News Daily News

EES Reduce Revascularization vs. BMS Regardless of Kidney Disease Severity

January 09, 2014

News Daily News

Comparados con los SMD, los SLE Reducen la Revascularización con Independencia de la Severidad de la Enfermedad Renal

January 09, 2014

Presentation

Randomized Comparison of Xience V and Multi-link Stents in the Same Multivessel Patient with CKD

Presenter: Fabrizio Tomai

January 07, 2014

News Daily News

RE-LY: Dabigatran Safe, Effective Across Range of Renal Function

Yael L. Maxwell

December 30, 2013

News Daily News

RE-LY: Dabigatran es Seguro y Eficaz en Todos los Rangos de Función Renal

Yael L. Maxwell

December 30, 2013

News Daily News

RE-LY：达比加群在不同肾功能患者中安全、有效

Yael L. Maxwell

December 30, 2013

Advertisement

Global SYMPLICITY Substudy Teases out Reasons for Non-response in Real-World Patients

Many Patients Referred for Renal Denervation Improve with Medication Adjustment

Eligibility for Renal Denervation: Experience at 11 European Expert Centers

A-fib, Dialysis Dramatically Worsen Outlook for TAVR Patients with Advanced CKD

Renal Denervation Shows Promise in Patients Refractory to Stenting

Renal Denervation for Hypertension Refractory to Renal Artery Stenting

ACC 2014 Late Breaking Trials Renal Denervation for Resistant Hypertension

Renal Artery Intervention and Denervation for Resistant Hypertension

ACC/i2 2014: Cardiologists Carefully Consider TAVR, Renal Denervation

Global SYMPLICITY Registry Still Shows Positive Results for Renal Denervation

Renal Denervation Fails to Meet Efficacy Endpoints Compared with Placebo Procedure

Una Prueba No Invasiva asocia el Volumen de Fluido Pre-Angiografía a Futuros Daños Renales

Noninvasive Test Links Pre-Angiography Fluid Volume to Later Kidney Damage

Preprocedural Bioimpedance Vectorial Analysis (BIVA) of Fluid Status and Prediction of Contrast-Induced AKI

EES Reduce Revascularization vs. BMS Regardless of Kidney Disease Severity

Comparados con los SMD, los SLE Reducen la Revascularización con Independencia de la Severidad de la Enfermedad Renal

Randomized Comparison of Xience V and Multi-link Stents in the Same Multivessel Patient with CKD

RE-LY: Dabigatran Safe, Effective Across Range of Renal Function

RE-LY: Dabigatran es Seguro y Eficaz en Todos los Rangos de Función Renal

RE-LY：达比加群在不同肾功能患者中安全、有效

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content